While it is commonly linked to metastasis and poor prognosis in various malignancies, including BC [20], our analysis revealed that CD36 was significantly downregulated in the BC cohort, particularly in ER-, PR-, HER2+, TNBC, and basal-like subtypes. Here, CD36 is linked to breast cancer.